Mark A. Karwal, M.D.
Clinical Associate Professor
Dr. Karwal's clinical interest is in general hematology and oncology.
Honors, Awards, and Organizations
- American Society of Hematology
- Phi Beta Kappa
- American Cancer Society Clinical Fellowship
Recent Publications
- Dreicer, R., Karwal, M.W., Midence, G. 1994. Radioculide Angiocardiography Assessment of Doxorubicin Cardiac Toxicity in the 1990's: A Reappraisal. Proc. Amer. Soc. Clinical Oncology, Vol 13, p. 149.
- Karwal, M.W., Riggs, C.E., Jr., and Davis, R.T. 1994. Successful treatment of Casatleman's Disease (Plasma Cell Type) with infusional viscristine, doxorubicin, and dexamethasone (VAD-2) chemotherapy. Blood, Vol. 84, p.655a, November 15, 1994.
|
Medical School:
The University of Iowa
Residency:
Iowa Methodist Medical Center/VA Medical Center
Fellowship:
The University of Iowa |
